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Foxn1 helps to determine whether 
pigment is deposited in the skin ver-
sus the hair, as the authors suggest, 
what regulates Foxn1 to give rise to 
such patterns? Finally, exactly how 
might Foxn1 act in an instructive way 
to stimulate pigment acquisition?
With regard to this last question, 
Weiner et al. find that Foxn1 regulates 
expression of fibroblast growth factor 
2 (Fgf2), and that antibodies against 
Fgf2 prevent ectopic pigment cells 
from colonizing the epidermis of the 
transgenic mice that express Foxn1 
in basal keratinocytes. In this context, 
Fgf2 may be acting like Kitl (Figure 1), 
that is, to stimulate migration and/or 
proliferation of melanocytes in such 
a way that they are recruited to, and 
remain in, the interfollicular epidermis. 
However, a mechanism mediating the 
potential role for the Foxn1-Fgf2 axis 
in the hair follicle would be differ-
ent from that involving Kit1, because 
Foxn1 in the follicle affects the inter-
actions between keratinocytes and 
melanocytes, not their numbers or 
location. Weiner et al. speculate that 
Foxn1 may “instruct” keratinocytes 
to receive pigment directly from 
melanocytes; unfortunately, there is 
almost nothing known about the cell 
biology of pigment transfer, and it is 
not clear how to test this idea. How-
ever, some simple experiments may 
prove illuminating. Given the previous 
work on Kit and Kitl, it is not known 
whether specification of the “pigment 
cell recipient phenotype” by Foxn1 
requires Kit, a question that could 
be addressed using either a genetic 
approach or neutralizing antibodies. 
Another prediction of the authors’ 
model is that specific expression of 
Foxn1 in suprabasal keratinocytes 
(using for example a Keratin 10 pro-
moter) would cause pigment transfer 
to skip the basal layer of the epider-
mis and be directed instead to more 
superficial layers.
Regardless of the answer to these 
questions (which focus mainly on 
the epidermis and the relationship 
between Foxn1 and Kit signaling), the 
Weiner et al. study sheds light on one 
of the longstanding mysteries of the 
hair follicle: how the hair shaft gets its 
pigment. Clearly, making a complete 
hair follicle requires more than just 
building it.
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How do antibiotics actually work? Although the primary cellular targets of many antimicrobial 
agents have been identified, the downstream events leading to bacterial cell death remain 
unclear. In this issue, Kohanski et al. (2007) provide evidence that the production of reactive 
oxygen species is a shared mechanism of cell death initiated by bactericidal antibiotics.Despite the importance of antimi-
crobial agents in the health care and 
agricultural sectors and almost a cen-
tury of research and discovery, death 
of bacteria in response to antibiotic 
exposure largely remains a black box. 
We can readily measure the physi-
ological effects of antibiotics, such as 
loss of membrane permeability and changes in cell morphology, as well 
as molecular events, such as inhibi-
tion of cellular pathways. However, the 
consequences for microbial molecu-
lar networks triggered by exposure to 
antibiotics that underlie these events 
remain obscure. Furthermore, it is not 
clear whether there is a single major 
mechanism of bacterial cell death Cell 130, Sepfrom antibiotics or many. Is it possible 
that antibiotics with diverse chemical 
structures that have dissimilar cellular 
targets share downstream events in 
common that result in bacterial death? 
At a first approximation, one would 
predict that there are likely to be many 
consequences of inhibiting essen-
tial cellular processes and that, as a tember 7, 2007 ©2007 Elsevier Inc. 781
result, there would be equally numer-
ous ways to achieve bacterial killing. 
However, one could also imagine that 
events downstream of diverse antibi-
otics converge on a vital cellular hub.
In this issue, Kohanski et al. (2007) 
provide evidence for such a hub in 
the action of bactericidal antibiot-
ics—the production of reactive oxy-
gen species. Using a clever fluores-
cence assay to measure production of 
hydroxyl radicals in bacterial cells, the 
authors explored the impact of known 
bactericidal antibiotics. These bacteri-
cidal antibiotics have different cellular 
targets: fluoroquinolones target topoi-
somerase, aminoglycosides target the 
ribosome, and β-lactams target pepti-
doglycan biosynthesis. Yet all three of 
these antibiotics induced the forma-
tion of reactive oxygen species when 
tested in both Gram-negative (Esche-
richia coli) and Gram-positive (Staphy-
lococcus aureus) bacteria. In contrast, 
bacteriostatic antibiotics, which halt 
bacterial growth but do not trigger cell 
death, do not induce the production of 
hydroxyl radicals. The bacteriostatic 
antibiotics tested included inhibitors 
of translation (chloramphenicol, tet-
racycline, erythromycin, and spec-
tinomycin) and transcription (rifamycin 
SV).
Using chemical rescue experiments 
(titration of bacterial cultures with the 
iron chelator 2,2′-dipyridyl or addi-
tion of the radical scavenger thiourea), 
Kohanski et al. were able to suppress 
the bactericidal, but not the bacte-
riostatic, effects of antibiotics. This 
experiment provides evidence that 
formation of hydroxyl radicals occurs 
via Fenton-like chemistry (oxidation 
of ferrous iron to ferric iron by per-
oxide, generating hydroxyl radicals). 
Additional support for this hypoth-
esis includes evidence that the SOS 
response (an inducible DNA repair 
pathway that responds to DNA dam-
age and oxidative stress) was initiated 
upon exposure to antibiotics and the 
observation that bacterial mutants 
impaired in the formation of iron-sul-
fur clusters (a logical source of iron) 
were less susceptible to bactericidal 
drugs. In addition, a marked deple-
tion of NADH (a source of reducing 
power to generate ferrous iron) fol-782 Cell 130, September 7, 2007 ©2007 lowing exposure to bactericidal drugs 
was observed, and impairment of the 
tricarboxylic acid (TCA) cycle, which 
lowers the steady-state concentra-
tion of NADH, also made bacteria less 
susceptible to bactericidal drugs. This 
spike in hydroxyl radical formation 
results in DNA and protein damage, is 
common to all bactericidal antibiotics 
tested in the study, and is a unifying 
theme in death of bacteria (Figure 1).
The new work by Kohanski et al. 
provides a theory of bacterial cell 
death induced by antibiotics wherein 
the inhibition of an essential pro-
cess—for example, cell-wall syn-
thesis—results in an increase in the 
concentration of intracellular hydroxyl 
radicals and damage to vital cell com-
ponents (DNA, proteins, membranes). 
Furthermore, this work nicely builds on 
research showing that antibiotics such 
as ciprofloxacin also induce the SOS 
figure 1. common Mechanisms of Bac-
terial cell Death Induced by Antibiotics
Antibiotics bind to their targets, disrupting 
normal cellular metabolism, including the tri-
carboxylic acid (TCA) cycle. This depletes 
intracellular NADH, which is paired with a 
commensurate rise in the production of re-
active oxygen species such as peroxide and 
superoxide. These reactive oxygen species 
interact with Fe2+ via Fenton chemistry to gen-
erate highly toxic oxygen radicals, which react 
with DNA and proteins, resulting in death of 
bacteria.Elsevier Inc.response and that the SOS response 
is a key step in the development of 
antibiotic resistance (Cirz et al., 2005, 
2006). The SOS response includes the 
production of proteins involved in the 
repair of DNA damage such as RecA 
and protein folding agents such as 
chaperones. The repair of DNA dam-
age is frequently accompanied by tol-
erance of minor gene mutations that 
can contribute to antibiotic resistance. 
Cell death and antibiotic resistance 
may therefore be connected through 
the production of hydroxyl radicals.
This growing body of evidence link-
ing the action of antibiotics and the 
cellular response to macromolecular 
damage caused by hydroxyl radicals 
can now be exploited in the develop-
ment of new antibacterial agents. Not 
only can inhibitors of the DNA damage 
response suppress the emergence 
of antibiotic resistance (especially 
when the drug is present in sublethal 
concentrations) (Cirz et al., 2005); as 
the work of Kohanski et al. suggests, 
such inhibitors may also potentiate 
the actions of bactericidal antibiotics. 
In fact, RecA inhibitors are currently 
under development (Lee et al., 2005). 
This strategy should be applicable to 
any other key proteins in the response 
to hydroxyl radicals. These may have 
been overlooked in previous efforts 
to identify new potential targets of 
antibiotics, as they generally are not 
essential for cell growth. Furthermore, 
the facile fluorescence assay used by 
Kohanski et al. to detect hydroxyl radi-
cals within cells could find use as an 
important secondary assay for rapid 
identification of candidate bactericidal 
antibiotics during screens for new 
agents.
The concept of antibiotic poten-
tiation by compounds that inhibit 
important (though perhaps nones-
sential) metabolic pathways is a wor-
thy alternative strategy to the “one 
compound, one target” approach 
that has dominated drug discov-
ery. Although the development of 
antibiotics using this combinatorial 
approach presents challenges with 
respect to clinical trials and associ-
ated regulatory hurdles, it is instruc-
tive to recall that one of the most 
important and profitable antibiotics 
in current clinical use, Augmentin, is 
a combination of an inhibitor of drug 
resistance and an antibiotic. Inhibi-
tion of downstream repair efforts by 
bacteria in response to antibiotics 
could serve as the final knockout 
punch for bacterial pathogens.RefeRences
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